Ads
-
Related paper
- Lung Cancer of Unknown Primary Site with EGFR Mutation as Indicated by Frozen Bone Specimen
- EGFR and KRAS Oncogene Expressions Among Lung Cancer Patients in North Sumatera
- Comparison of EGFR with Other Molecular, Demographic and Clinicopathologic Data in Nonsmall Cell Lung Carcinoma: A Study from Tertiary Cancer Centre from Western Part of India
- Extracellular Domain Mutation of ErbB2 Status in Japanese Lung Cancer Patients
- The diagnostic value of the p16ink marker for verification of tumors of unknown primary site in women with isolated lesion of inguinal lymph nodes
- Brigatinib treatment for primary lung lesions in non-small-cell lung cancer based on ALK gene rearrangement detected in resected brain metastases: A case report and literature review
- Nanopharmaceutical Approach for Enhanced Anti-cancer Activity of Betulinic Acid in Lung-cancer Treatment via Activation of PARP: Interaction with DNA as a Target -Anti-cancer Potential of Nano-betulinic Acid in Lung Cancer-
- The Future of Telerehabilitation in Lung Cancer: An Observational Study Investigating Access to Technology in the Lung Cancer Population
- SALIVARY EGFR AS BIOMARKER FOR ORAL CANCER & PRE-CANCER :A CASE CONTROL STUDY
- Post-cancer Treatment with Condurango 30C Shows Amelioration of Benzo[a]pyrene-induced Lung Cancer in Rats Through the Molecular Pathway of Caspase-3-mediated Apoptosis Induction -Anti-lung cancer potential of Condurango 30C in rats-